Paul Oberstein

Trials

Studies that name Paul Oberstein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:03 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT05984602 · A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer

  NYU Langone Health · active not recruiting · Pancreatic Cancer · principal investigator
• N/A
  NCT05483075 · Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer

  NYU Langone Health · completed · Pancreatic Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.